We also assessed the co-expression of PD-L1 and markers that define specific immune cell subpopulations: CD4 and CD8 for lymphocytes, FoxP3 for regulatory cells, and CD68 for macrophages, as well as PD-L1 expression in cytokeratin-positive tumor cells. Here, CD274 is linked to neoplasm.